PharmaShots Weekly Snapshot (May 04-08, 2020)
1.Fitbit Launches Heart Study to Validate its Wearable Technology for Identifying Atrial Fibrillation
Published: May 06, 2020 | Tags: Fitbit, Launches, Heart Study, Validate, Wearable Technology, Identifying, Atrial Fibrillation
Published: May 07, 2020 | Tags: Celltrion, Launches, Remsima SC, biosimilar, infliximab, Treatment, Autoimmune Diseases, Netherlands
3. ?? GSK to Evaluate Otilimab for Treating Pulmonary Disease Associated with COVID-19
Published: May 06, 2020 | Tags: GSK, Evaluate, Otilimab, Treating, Pneumonia, Associated, COVID-19
Published: May 07, 2020 | Tags: CoVIg-19 Plasma Alliance, Initiate, Clinical Study, Evaluating, Hyperimmune Therapy, COVID-19, Summer 2020
5. ? Moderna Anticipates the Initiation of P-III Study of mRNA-1273 for COVID-19 by Early Summer
Published: May 07, 2020 | Tags: Moderna, Anticipates, Initiation, P-III, Study, mRNA-1273, COVID-19, Early Summer
6. Gileads Veklury (remdesivir) Receives MHLWs Approval for Patients with Severe COVID-19 in Japan
Published: May 07, 2020 | Tags: Gilead, Veklury, remdesivir, Receives, MHLW, Approval, Patients, Severe, COVID-19, Japan
Published: May 06, 2020 | Tags: Laurent, Receives, Health Canada, Approval, Initiate, P-II, RESOLUTION, Study, Evaluating, LAU-7b, COVID-19
Published: May 06, 2020 | Tags: Amgen, Reports, Results, Otezla, apremilast, P-III, ADVANCE, Study, Mild-To-Moderate, Plaque Psoriasis
Published: May 06, 2020 | Tags: Bausch + Lomb, Signs, Exclusive, License Agreement, STADA, Xbrane, Xlucane, biosimilar, ranibizumab, US, Canada
Published: May 06, 2020 | Tags: Novartis, Incyte, Tabrecta, capmatinib, INC280, Receives, US, FDA, Approval, Metastatic Non-Small Cell Lung Cancer, METex14
11. PTC Therapeutics to Acquire Censa Pharmaceuticals to Bolster its Rare Disease Portfolio
Published: May 06, 2020 | Tags: PTC Therapeutics, Acquire, Censa Pharmaceuticals, Bolster, Rare Disease Portfolio
Published: May 05, 2020 | Tags: Sanofi, Regeneron, Report, Results, Libtayo, cemiplimab, P-II, Study, 2L, Treatment, Advanced Basal Cell Carcinoma
13. Bavarian Nordic Collaborates with AdaptVac to Advance COVID-19 Vaccine Program
Published: May 06, 2020 | Tags: Bavarian Nordic, Collaborates, AdaptVac, Advance, COVID-19, Vaccine Program
14. Regeneron Anticipates the Initiation of Clinical Study for its COVID-19 Antibody Cocktail in June
Published: May 05, 2020 | Tags: Regeneron, Anticipates, Initiation, Clinical Study, COVID-19, Antibody Cocktail, June
Published: May 05, 2020 | Tags: NeoGenomics, Collaborate, Bayer, Provide, NTRK Testing, Colorectal, Thyroid Cancer Patients
16. Pfizer and BioNTech Report First Patient Dosing with BNT162 in P-I/II Study for COVID-19 in the US
Published: May 05, 2020 | Tags: Pfizer, BioNTech, Reports, First Patient Dosing, P-I/II, Study, BNT162, COIVD-19, US
Published: May 04, 2020 | Tags: Bio-Rad, Receives, US, FDA, Emergency Use Authorization, Droplet Digital PCR Test Kit, Detect, COVID-19
18. Alexion to Acquire Portola for ~$1.41B
Published: May 05, 2020 | Tags: Alexion, Acquire, Portola, Expand, Commercial Portfolio, $1.14B
19. Vir and Alnylam Anticipate the Initiation of Clinical Study Assessing VIR-2703 By the Year End
Published: May 04, 2020 | Tags: Vir, Alnylam, Anticipate, Initiation, Clinical Study, Assessing, VIR-2703, By the Year End
20. Lilly and Junshi Collaborate to Co-Develop Antibody Therapies for the Treatment of COVID-19
Published: May 04, 2020 | Tags: Lilly, Junshi, Collaborate, Co-Develop, Antibody Therapies, Treatment, COVID-19
Published: May 04, 2020 | Tags: Teva, Celltrion, Launch, Truxima, biosimilar, rituximab, Treat, Wegeners Granulomatosis, Microscopic Polyangiitis, US
22. Roche Receives FDAs Emergency Use Authorization for its Elecsys to Detect COVID-19
Published: May 03, 2020 | Tags: Roche, Receives, FDA, Emergency Use Authorization, Elecsys, COVID-19
23. MHLW Expedites the Reviews of Gileads Remdesivir to Treat Patients with COVID-19 in Japan
Published: May 04, 2020 | Tags: MHLW, Expedites, Reviews, Gilead, Remdesivir, Treat, Patients, COIVD-19, Japan
24. ? Revance and Mylan to Extend Biosimilar to BOTOX Program Decision Beyond April 30, 2020
Published: May 01, 2020 | Tags: Revance, Mylan, Extend, Biosimilar, BOTOX, Program Decision, Beyond, April 30, 2020
25. Gileads Remdesivir Receives the US FDAs Emergency Use Authorization for the Treatment of COVID-19
Published: May 01, 2020 | Tags: Gilead, Remdesivir, Receives, US, FDA, Emergency Use Authorization, Treatment, COVID-19
Tags
This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com